Avestria Ventures

Curio is a digital asset investment platform specializing in the tokenization of collectible and rare cars. By leveraging blockchain technology, particularly on networks like Ethereum, Curio aims to simplify the investment process in this lucrative asset class, which has outperformed traditional financial indices since 2008. The company provides an innovative solution that eliminates high capital requirements, making it more accessible for a wider range of investors to participate in the collectible car market. Curio's mission focuses on pioneering the adoption of distributed ledger technologies in the automotive sector, enabling individuals to invest directly in prestigious vehicles without the need for costly intermediaries. Through its analytics engine and tailored approaches, Curio seeks to revolutionize how people engage with and invest in high-value collectibles.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in developing solutions for urinary incontinence and chronic fecal incontinence, conditions that are often underreported. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic that provides at-home treatment options. Utilizing patented technology, the system offers non-invasive and drug-free solutions by providing real-time visualization of pelvic floor movements while monitoring progress and usage. This approach enables women to effectively strengthen their pelvic floor muscles and alleviate symptoms associated with various types of incontinence, including stress, mixed, and urgency incontinence.

May Health specializes in developing innovative solutions for infertility related to Polycystic Ovary Syndrome (PCOS). The company offers a minimally invasive procedure aimed at restoring ovulation in women with PCOS, providing a more natural approach to pregnancy. This one-time treatment is performed transvaginally under ultrasound guidance, eliminating the need for general anesthesia. The procedure is designed to assist the body's natural ovulation process and can be conducted in a clinical setting, similar to techniques used by fertility specialists in in vitro fertilization (IVF). May Health's focus is on delivering effective, durable solutions for patients seeking to conceive while minimizing the medicalization of the pregnancy experience.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Avation Medical, Inc. is focused on developing a non-invasive closed-loop neuromodulation system designed for the at-home treatment of overactive bladder. Established in 2016 and based in Columbus, Ohio, the company is pioneering wearable nerve stimulation platforms that emphasize patient empowerment and personalized care. By re-imagining neuromodulation through innovative, proven technologies, Avation Medical aims to enhance the management of chronic conditions, offering solutions that prioritize the needs and experiences of patients.

Axena Health is a women-led company focused on enhancing the lives of women suffering from pelvic floor disorders through innovative digital technology. The company specializes in developing solutions for urinary incontinence and chronic fecal incontinence, conditions that are often underreported. Its flagship product, the Leva Pelvic Health System, is a prescription digital therapeutic that provides at-home treatment options. Utilizing patented technology, the system offers non-invasive and drug-free solutions by providing real-time visualization of pelvic floor movements while monitoring progress and usage. This approach enables women to effectively strengthen their pelvic floor muscles and alleviate symptoms associated with various types of incontinence, including stress, mixed, and urgency incontinence.

AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.

Rhinostics is a company focused on enhancing laboratory workflows through innovative sample collection solutions. Its products are designed to improve the efficiency, accuracy, and safety of laboratory operations, particularly for tests such as COVID-19. By introducing new materials and collection methods, Rhinostics streamlines the sample intake process, allowing for rapid accessioning and high-throughput workflows with minimal human intervention. This approach not only reduces costs and time associated with traditional sample collection but also helps to lower labor costs, improve safety, and decrease sample contamination and error rates.

AOA, based in Boston, New York, and London, is a female-led company focused on developing innovative cancer diagnostics specifically for women's health. The company is dedicated to creating the first accurate early-stage liquid biopsy test for ovarian cancer, which aims to enhance clinical practices, reduce patient mortality, and offer cost savings for healthcare payers. Utilizing an artificial intelligence-enabled platform, AOA's technology analyzes tumor marker gangliosides to facilitate the early detection of ovarian cancer. This approach not only helps healthcare providers implement more effective treatment strategies but also ensures that patients can access life-saving treatments sooner and at a more affordable cost.

Fogarty Innovation is a nonprofit organization based in Mountain View, California, focused on advancing medical innovation to enhance human health. Founded in 2007, the organization supports promising innovators and researchers by transforming their creative ideas into practical solutions that improve patient care. It operates as an incubator, providing essential funding, mentorship, and research tools to facilitate the development of medical concepts from inception to application. Fogarty Innovation offers two key programs: one aimed at fostering innovation for startups and another dedicated to educating the next generation of inventors. Through these initiatives, Fogarty Innovation coordinates access to vital intellectual, physical, and financial resources to drive medical advancements.

Raydiant Oximetry, Inc. is a medical device company founded in 2015 and headquartered in Mountain View, California. The company focuses on improving childbirth outcomes for mothers and infants by developing a low-cost, non-invasive device that monitors fetal oxygen levels during labor. This innovative technology aims to provide real-time insights into fetal oxygenation, which can help clinicians make informed decisions and reduce the risks associated with childbirth, such as birth injuries and unnecessary cesarean sections. By enhancing patient care and potentially lowering healthcare costs, Raydiant Oximetry's device addresses critical needs in maternal and fetal health.

Mae is a women's health care center providing pregnancy and postpartum support, tailored to women's needs. Mae is establishing a world in which high-quality, proactive care is the norm. Mae improves the quality of care for Black women by providing a trusted, digital-first health platform.

Rhinostics is a company focused on enhancing laboratory workflows through innovative sample collection solutions. Its products are designed to improve the efficiency, accuracy, and safety of laboratory operations, particularly for tests such as COVID-19. By introducing new materials and collection methods, Rhinostics streamlines the sample intake process, allowing for rapid accessioning and high-throughput workflows with minimal human intervention. This approach not only reduces costs and time associated with traditional sample collection but also helps to lower labor costs, improve safety, and decrease sample contamination and error rates.

Alydia Health, Inc. is a medical device company based in Menlo Park, California, focused on addressing postpartum hemorrhage (PPH), a leading cause of maternal mortality. The company designs and manufactures the Jada System, a device that effectively stops excessive bleeding by promoting natural uterine contractions after childbirth. This innovative solution utilizes a vacuum-induced tamponade effect, enabling the body to control postpartum hemorrhage without the need for pharmaceuticals or surgical interventions. Founded in 2010 and rebranded from InPress Technologies in 2018, Alydia Health aims to significantly enhance the treatment options for PPH, ultimately improving the health outcomes of women globally and reducing healthcare costs associated with maternal care.

Knowledge to Practice is a company focused on enhancing postgraduate medical education through innovative education technology. Founded in 2014 and based in Bethesda, United States, it provides self-directed learning solutions, assessment tools to identify knowledge gaps, and content modules for repeated review. The platform is designed to assist clinical leaders in delivering personalized curricula that utilize advanced learning techniques. By improving clinical judgment, critical thinking, and patient care, Knowledge to Practice aims to enable physicians to enhance their performance and reduce variations in care.

Raydiant Oximetry, Inc. is a medical device company founded in 2015 and headquartered in Mountain View, California. The company focuses on improving childbirth outcomes for mothers and infants by developing a low-cost, non-invasive device that monitors fetal oxygen levels during labor. This innovative technology aims to provide real-time insights into fetal oxygenation, which can help clinicians make informed decisions and reduce the risks associated with childbirth, such as birth injuries and unnecessary cesarean sections. By enhancing patient care and potentially lowering healthcare costs, Raydiant Oximetry's device addresses critical needs in maternal and fetal health.